No Data
HAITONG SEC: The trend of moderate price reductions in the centralized procurement of Traditional Chinese Medicine varieties continues, and the domestic Pharmaceutical industry is expected to usher in a wave of mergers and acquisitions.
HAITONG SEC released a Research Report stating that the gentle trend of price reduction for Traditional Chinese Medicine varieties continues.
Hong Kong's Department of Health: To develop Hong Kong into a gateway for the internationalization of traditional Chinese medicine and Chinese herbal medicine.
Secretary for Food and Health of the Hong Kong Special Administrative Region, Dr. Constance Chan, stated that in order to promote the standardization and internationalization of traditional chinese medicine, Hong Kong aims to become a gateway for the internationalization of traditional chinese medicine.
【Industry Trends】In 2024, on-site negotiations and bidding for medical insurance directory have begun; the cumulative number of licenses issued for domestic online games has exceeded one thousand.
In 2024, the on-site negotiation bidding for the medical insurance catalog will begin, and the results are scheduled to be announced at 8:30 a.m. on November 10 after starting officially in peking on October 27. According to the previously released information, from today (the 27th) to the 30th, a total of 162 pharmaceuticals will participate in the on-site negotiation and bidding. It is reported that this year, like before, there will be 25 negotiation experts from medical insurance departments selected from all over the country, divided into 5 groups, conducting negotiations on medical insurance payment prices, officially kicking off the medical insurance on-site negotiation and bidding. Source: CCTV news China's steel exports in the first three quarters of this year reached 8.
Capital flow statistics of Stock Connect (T+2) on Smart Investment Hong Kong | October 24th
Intelligent Hong Kong Stock Connect capital trend | October 24th
HK Stock Market News | trad chi med (00570) rebounded by more than 5%, the privatization plan failure led to a sharp drop in stock price, Beishui acquired over 0.9 billion Hong Kong dollars in a single day.
Trad chi med (00570) rebounded by more than 5%, as of press time, up 5.24%, at 2.61 Hong Kong dollars, with a turnover of 0.402 billion Hong Kong dollars.
Trad Chi Med (00570.HK) received JPMorgan's shareholding of 19.8572 million shares.
On October 22, according to the latest equity disclosure data from the Hong Kong Stock Exchange, on October 16, 2024, trad chi med (00570.HK) received JPMorgan Chase & Co.'s shareholding of 19.8572 million shares at an average price of HKD 4.334 per share, involving approximately 86.0613 million Hong Kong dollars. After the shareholding, JPMorgan Chase & Co.'s latest holding of shares is 262,837,629 shares, and the shareholding ratio has increased from 4.82% to 5.21%.
No Data
933199333 : I also buy no need thank you me.